Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -358.04% is 402% below its 5-year average of -71.31%, near the low end of its 5-year range (-473.92%–-11.95%).
As of the fiscal period ended Tuesday, June 30, 2026. 21.30% below its 12-month average of -295.17%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -358.04%.
RETURN ON INVESTED CAPITAL (ROIC)
-358.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-295.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-128.50%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-71.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-21.30%
CURRENT VS 3Y AVG
-178.64%
CURRENT VS 5Y AVG
-402.11%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 603 covered companies
CURRENT VS SECTOR MEDIAN
-929.75%
vs the sector median at left
Lantern Pharma Inc.
Market Cap
$11.83M
Return on Invested Capital (ROIC)
-358.04%
TTM Avg
-295.17%
3Y Avg
-128.50%
5Y Avg
-71.31%
Market Cap
$11.31M
Return on Invested Capital (ROIC)
-86.22%
TTM Avg
-227.24%
3Y Avg
-220.51%
5Y Avg
-220.51%
Market Cap
$11.26M
Return on Invested Capital (ROIC)
-59.42%
TTM Avg
-18.05%
3Y Avg
-54.95%
5Y Avg
-57.91%
Market Cap
$12.41M
Return on Invested Capital (ROIC)
-19.53%
TTM Avg
-16.13%
3Y Avg
-40.26%
5Y Avg
-33.39%
Market Cap
$11.21M
Return on Invested Capital (ROIC)
-240.64%
TTM Avg
-174.03%
3Y Avg
-198.05%
5Y Avg
-242.53%
Market Cap
$11.13M
Return on Invested Capital (ROIC)
-32.27%
TTM Avg
-112.80%
3Y Avg
-113.13%
5Y Avg
-94.20%
Market Cap
$12.58M
Return on Invested Capital (ROIC)
-203.50%
TTM Avg
-154.20%
3Y Avg
-205.70%
5Y Avg
-169.89%
Market Cap
$11.01M
Return on Invested Capital (ROIC)
-216.67%
TTM Avg
-46.84%
3Y Avg
-98.66%
5Y Avg
-549.86%
Market Cap
$10.98M
Return on Invested Capital (ROIC)
-479.39%
TTM Avg
-317.58%
3Y Avg
-249.47%
5Y Avg
-183.14%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lantern Pharma Inc. (LTRN) | $11.83M | -358.04% | -295.17% | -128.50% | -71.31% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.31M | -86.22% | -227.24% | -220.51% | -220.51% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.26M | -59.42% | -18.05% | -54.95% | -57.91% |
| IRIDEX Corporation (IRIX)vs › | $12.41M | -19.53% | -16.13% | -40.26% | -33.39% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.21M | -240.64% | -174.03% | -198.05% | -242.53% |
| Biofrontera Inc. (BFRI)vs › | $11.13M | -32.27% | -112.80% | -113.13% | -94.20% |
| Dare Bioscience, Inc. (DARE)vs › | $12.58M | -203.50% | -154.20% | -205.70% | -169.89% |
| BioVie Inc. (BIVI)vs › | $11.01M | -216.67% | -46.84% | -98.66% | -549.86% |
| Cerenome, Inc. (CNSY)vs › | $10.98M | -479.39% | -317.58% | -249.47% | -183.14% |
| Cytosorbents Corporation (CTSO)vs › | $12.69M | -43.31% | -42.56% | -55.36% | -44.03% |
ROIC
-358.0%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -358.04% |
| 2026-03-31 | -473.92% |
| 2025-12-31 | -275.14% |
| 2025-09-30 | -205.20% |
| 2025-06-30 | -163.55% |
| 2025-03-31 | -126.46% |
| 2024-12-31 | -104.59% |
| 2024-09-30 | -79.41% |
| 2024-06-30 | -63.07% |
| 2024-03-31 | -54.00% |
| 2023-12-31 | -43.64% |
| 2023-09-30 | -36.97% |
| 2023-06-30 | -31.91% |
| 2023-03-31 | -27.80% |
| 2022-12-31 | -25.76% |
| 2022-09-30 | -23.92% |
| 2022-06-30 | -26.40% |
| 2022-03-31 | -21.74% |
| 2021-12-31 | -17.54% |
| 2021-09-30 | -15.80% |
| 2021-06-30 | -11.95% |
| 2021-03-31 | -9.63% |
| 2020-12-31 | -29.83% |
| 2020-09-30 | -17.01% |
| 2020-06-30 | -11.33% |
| 2020-03-31 | -415.69% |
| 2019-12-31 | -257.42% |
